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As a result of an experimental confluence between carcinogenesis and oxidative phosphorylation, we published in 1971 
‘A Unitary Hypothesis for Carcinogenesis’ [(1971) J. Antibiot. Tokyo 24, 4054171. According to this hypothesis, 
damaged mitochondria release mitochondrial genetic material which like that from an oncogenic virus could enter the 
nuclear genome. Our original hypothesis and its justification cover the hypothesis recently presented by Dr C. Richter 
[(1988) FEBS Lett. 241, l-51. 
Mitochondrial DNA; Carcinogenesis 
During the 1970s we reported [l-13] that many 
metabolites of carcinogens, and in some instances 
the carcinogen itself, interfered with the mitochon- 
drial process of oxidative phosphorylation. The 
carcinogens, the metabolites, and certain related 
compounds, covered a wide range of structures 
(e.g. polynuclear hydrocarbons, hydroxyquinones, 
arylamides, arsenate, . . .). The effects on oxidative 
phosphorylation were diverse (e.g. respiratory in- 
hibitors, uncoupling agents, inhibitors of 
respiratory linked phosphorylation, . . .). Because 
of this experimental confluence between car- 
cinogenicity and oxidative phosphorylation, we 
presented a unitary hypothesis for carcinogenesis 
[l] which was stated in the abstract as follows, 
“ . . . when mitochondria were damaged genetic 
material could be released from the mitochondria. 
The released genetic material could behave like an 
oncogenic virus and enter the nuclear genome.” 
This hypothesis was not restricted to chemical car- 
cinogenesis, but included any means of damaging 
the mitochondria. 
In 1971 when this hypothesis was published [l] 
it had been unpopular for some time [ 14,151 to link 
carcinogenesis to either an impairment of respira- 
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tion, or to damage of the mitochondria, as sug- 
gested by Warburg [16] many years previously. It 
should be noted, however, that Woods and Burk 
[ 171 had proposed in 1965 that an alteration in 
mitochondrial genetic material was associated with 
cancer. Our hypothesis involved what today is 
called, mobile genetic units and insertional 
mutagenesis [18]. Two important reviews, the first 
[ 191 dealing with mitochondrial bioenergetics and 
cancer, and the second [20] dealing with the 
transfer of mitochondrial genes to the nucleus, 
drew significant attention to our unitary hypo- 
thesis for carcinogenesis. In addition, an aim of 
the first review [19] was to ‘stimulate additional 
research and funding for this important but rather 
neglected area’. 
A good hypothesis should lead to otherwise 
unanticipated investigations [5]. Thus, we reported 
[21] that mitochondrial DNA and nuclear DNA 
from normal rat liver, have a common sequence. 
This was an unexpected observation at the time 
when it was made and suggested that rat mitochon- 
drial DNA-like sequences in the nuclear genome 
could not only be relevant to transformation but 
also to evolution, development, aging and 
pathological conditions. 
Recently Dr Christoph Richter [22] published 
the hypothesis, ‘Do mitochondrial DNA fragments 
promote cancer and aging’. What Dr Richter pro- 
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posed, has already been presented as our original 
unitary hypothesis for carcinogenesis [l] and in 
our later publications [2-13,211. Dr Richter did 
not mention the originality of our unitary 
hypothesis for carcinogenesis even though he cited 
the above two important reviews [19,20] which 
gave prominence to our publications and our 
hypothesis and which were germane to his article. 
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